Transaction #1464 · Form 4 · 0001995009-25-000003
Lexeo Therapeutics, Inc. · Stock award · Common Stock
Lexeo Therapeutics, Inc. · Transacted October 15, 2025 · Filed October 17, 2025
What does this filing report?
An SEC Form 4 filing for Lexeo Therapeutics, Inc. records a stock award involving Common Stock on October 15, 2025. The reported quantity was 9,900. The filing date is October 17, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Lexeo Therapeutics, Inc.
- Company CIK
- 0001907108
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 9,900
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 72,456
- Ownership description
- Not reported
- SEC acceptance time
- Oct 17, 2025, 7:28 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Robertson Jenny ↗
Chief Legal Officer
CIK 0001995009
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents a sale to cover tax obligations on the release of Restricted Stock Units ("RSUs").
- F2
- This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F3
- This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F4
- Includes 51,092 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.